ASCEND Cardiovascular, leader in cardiovascular structured reporting and workflow solutions is partnering with Us2.ai to add fully automated echocardiography analysis and CV disease detection reporting to its suite of seamlessly integrated cardiovascular image visualization and reporting solutions. When integrated with InViewTM, ASCEND’s high-performance zero-footprint Cardiovascular viewer, Us2.ai’s FDA-cleared and CE Marked echocardiogram algorithms automate measurements and pre-populate [...]
Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai.
Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report
Save time with single-click navigation to the automated measurement source frame
1-click sync to automated measurement frame
Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity
Automatic grouping of Us2.ai measurements accelerates the measurement review process
Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability
Engineered for seamless integration: Gen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration.
Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.
Your document has finished loading